Literature DB >> 7706827

Human intestinal cryptosporidiosis: secretory diarrhea and enterotoxic activity in Caco-2 cells.

A Guarino1, R B Canani, A Casola, E Pozio, R Russo, E Bruzzese, M Fontana, A Rubino.   

Abstract

A cell line model to detect enterotoxic effect was used to test fecal specimens of patients with enteric cryptosporidiosis. Fecal samples were obtained from 11 patients with Cryptosporidium diarrhea, and osmotic gap was determined. Caco-2 cell monolayers grown on filters were mounted in Ussing chambers, and electrical parameters were measured before and after the addition of fecal supernatant. A significant increase in short-circuit current was seen in 9 of 11 specimens. The enterotoxic effect was time- and dose-dependent, saturable, and Cl(-)- and Ca(2+)-dependent. Fecal osmotic gap was consistent with secretory diarrhea in the 9 enterotoxin-positive but not in the 2 enterotoxin-negative samples. In conclusion, a cell line model for studying the pathophysiology of enteric cryptosporidiosis was established. Enterotoxic activity was observed in most patients with enteric cryptosporidiosis and was strictly associated with secretory diarrhea.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7706827     DOI: 10.1093/infdis/171.4.976

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Toxoplasma gondii: changes of transepithelial ion transport in infected HT29/B6 cell monolayers.

Authors:  Sabine Kowalik; W Clauss; H Zahner
Journal:  Parasitol Res       Date:  2003-12-09       Impact factor: 2.289

Review 2.  Management of gastrointestinal disorders in children with HIV infection.

Authors:  Alfredo Guarino; Eugenia Bruzzese; Giulio De Marco; Vittoria Buccigrossi
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

3.  Cytotoxic T cells in AIDS colonic cryptosporidiosis.

Authors:  D Reijasse; N Patey-Mariaud de Serre; D Canioni; M Huerre; E Haddad; M Leborgne; S Blanche; N Brousse
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

4.  In vivo and in vitro efficacy of octreotide for treatment of enteric cryptosporidiosis.

Authors:  A Guarino; R Berni Canani; M I Spagnuolo; M Bisceglia; M C Boccia; A Rubino
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

5.  Characterization of an intestinal epithelial cell receptor recognized by the Cryptosporidium parvum sporozoite ligand CSL.

Authors:  R C Langer; D A Schaefer; M W Riggs
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

6.  Inhibitory Effects of Two Varieties of Tunisian Pomegranate (Punica granatum L.) Extracts on Gastrointestinal Transit in Rat.

Authors:  Abdelaziz Souli; Hichem Sebai; Kais Rtibi; Latifa Chehimi; Mohsen Sakly; Mohamed Amri; Jamel El-Benna; Lamjed Marzouki
Journal:  J Med Food       Date:  2015-03-16       Impact factor: 2.786

7.  Effects of Salmonella typhimurium infection and ofloxacin treatment on glucose and glutamine metabolism in Caco-2/TC-7 cells.

Authors:  L Posho; L Delbos-Bocage; D Gueylard; R Farinotti; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

Review 8.  Cryptosporidiosis: an emerging, highly infectious threat.

Authors:  R L Guerrant
Journal:  Emerg Infect Dis       Date:  1997 Jan-Mar       Impact factor: 6.883

9.  Expression of tumor necrosis factor alpha and interleukin 1 beta in jejuna of volunteers after experimental challenge with Cryptosporidium parvum correlates with exposure but not with symptoms.

Authors:  P Robinson; P C Okhuysen; C L Chappell; D E Lewis; I Shahab; A Janecki; A C White
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

10.  Attachment of Cryptosporidium parvum sporozoites to human intestinal epithelial cells.

Authors:  A Joe; R Verdon; S Tzipori; G T Keusch; H D Ward
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.